ROMANO, MICOL
ROMANO, MICOL
Universita' degli Studi di MILANO
The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGS
2022 K. Cetin Gedik, L. Lamot, M. Romano, E. Demirkaya, D. Piskin, S. Torreggiani, L.A. Adang, T. Armangue, K. Barchus, D.R. Cordova, Y.J. Crow, R.C. Dale, K.L. Durrant, D. Eleftheriou, E.M. Fazzi, M. Gattorno, F. Gavazzi, E.P. Hanson, M.A. Lee-Kirsch, G.A. Montealegre Sanchez, B. Neven, S. Orcesi, S. Ozen, M.C. Poli, E. Schumacher, D. Tonduti, K. Uss, D. Aletaha, B.M. Feldman, A. Vanderver, P.A. Brogan, R. Goldbach-Mansky
Long Term Experience in Patients With JIA-Associated Uveitis in a Large Referral Center
2021 L. Marelli, M. Romano, I. Pontikaki, M.V. Gattinara, P. Nucci, R. Cimaz, E. Miserocchi
Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs
2020 G. Filocamo, F. Minoia, S. Carbogno, S. Costi, M. Romano, R. Cimaz
Patients with juvenile idiopathic arthritis on TNF inhibitors exposed to COVID-19 family members
2020 A. Marino, M. Romano, M. Gattinara, R. Cimaz
Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations : similarities and differences
2017 E.G. Favalli, I. Pontikaki, A. Becciolini, M. Biggioggero, N. Ughi, M. Romano, C. Crotti, M. Gattinara, V. Gerloni, A. Marchesoni, P.L. Meroni
Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients
2013 M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni
Juvenile idiopathic arthritis in adulthood : evaluation of disease activity, damage and quality of life
2011 A. Salmaso, M. Gattinara, I. Pontikaki, B. Teruzzi, N. Vaso, C. Donati, E. Shahi, M. Romano, P. Meroni, V. Gerloni